Swiss biotech company MindMaze Therapeutics has established its U.S. headquarters at The Pearl innovation district in midtown ...

XBI had a nice counter move of gains while the major indexes have rotated out of the AI leaders.

The company says recent investments in manufacturing and overseas expansion should start paying off over the next few ...

When Chinese drug developers need to see exactly how an experimental medicine binds to its target protein, or materials ...

Under the proposed FDA rule, distributed manufacturing establishments could register as a single establishment.

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

Startups are testing GLP-1 treatments for overweight cats while pet-food giants are leaning into longevity products as owners ...

USA News Group - News Commentary - Depression remains one of the most stubborn problems in modern medicine, and the numbers ...

The Indian government has published a 10-year national bioeconomy roadmap sector, which includes a focus on alternative ...

Kalshi, the next-generation financial exchange, today announced a partnership with public intelligence company AppliedXL to launch a pilot suite of prediction markets on clinical trial outcomes and ...

New therapies in the clinic for bipolar disorder hope to meet unmet needs of efficacy and minimal side effects.

ResMed's (ASX:RMD) reputation as the most resilient pillar of the Big Four life sciences stocks has come into question since ...